publication venue for
- Clinical Factors to Decide Between Sacral Neuromodulation and Onabotulinum Toxin-When Is One Clearly Better?. 12:328-336. 2017
- Outcomes for Intermittent Neuromodulation as a Treatment for Overactive Bladder. 12:66-73. 2017
- Relationship Between the Metabolic Syndrome and BPH-Related Voiding Dysfunction. 9:122-128. 2014